This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Docquier, F. Articles by Klenova, E. Search for Related Content PubMed PubMed Citation Articles by Docquier, F. Articles by Klenova, E.

Heightened Expression of CTCF in Breast Cancer Cells Is Associated with Resistance to Apoptosis

¹ Department of Biological Sciences, Central Campus, University of Essex, Essex; ² Genetics Unit, Department of Biochemistry, University of Oxford, Oxford; ³ LICR/UCL Breast Cancer Laboratory; ⁴ Department of Physiology, University College London, London, United Kingdom; and ⁵ Molecular Pathology Section, Laboratory of Immunopathology, NIAID/NIH, Rockville, Maryland

Requests for reprints: Elena Klenova, Department of Biological Sciences, University of Essex, Wivenhoe Park, Colchester, Essex CO4 3SQ, United Kingdom. Phone: 44-0-1206-874868; Fax: 44-0-1206-872592; E-mail: klenovae{at}essex.ac.uk.

CTCF is a candidate tumor suppressor gene encoding a multifunctional transcription factor. Surprisingly for a tumor suppressor, the levels of CTCF in breast cancer cell lines and tumors were found elevated compared with breast cell lines with finite life span and normal breast tissues. In this study, we aimed to investigate the possible cause for this increase in CTCF content and in particular to test the hypothesis that up-regulation of CTCF may be linked to resistance of breast cancer cells to apoptosis. For this purpose, apoptotic cell death was monitored following alterations of CTCF levels induced by transient transfection and conditional knockdown of CTCF in various cell lines. We observed apoptotic cell death in all breast cancer cell lines examined following CTCF down-regulation. In addition, overexpression of CTCF partially protected cells from apoptosis induced by overexpression of Bax or treatment with sodium butyrate. To elucidate possible mechanisms of this phenomenon, we used a proteomics approach and observed that levels of the proapoptotic protein, Bax, were increased following CTCF down-regulation in MCF7 cells. Taken together, these results suggest that in some cellular contexts CTCF shows antiapoptotic characteristics, most likely exerting its functions through regulation of apoptotic genes. We hypothesize that CTCF overexpression may have evolved as a compensatory mechanism to protect breast cancer cells from apoptosis, thus providing selective survival advantages to these cells. The observations reported in this study may lead to development of therapies based on selective reduction of CTCF in breast cancer cells.

This article has been cited by other articles:

				V. Torrano, J. Navascues, F. Docquier, R. Zhang, L. J. Burke, I. Chernukhin, D. Farrar, J. Leon, M. T. Berciano, R. Renkawitz, et al. Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism J. Cell Sci., May 1, 2006; 119(9): 1746 - 1759. [Abstract] [Full Text] [PDF]

				D. Klochkov, H. Rincon-Arano, E. S. Ioudinkova, V. Valadez-Graham, A. Gavrilov, F. Recillas-Targa, and S. V. Razin A CTCF-Dependent Silencer Located in the Differentially Methylated Area May Regulate Expression of a Housekeeping Gene Overlapping a Tissue-Specific Gene Domain. Mol. Cell. Biol., March 1, 2006; 26(5): 1589 - 1597. [Abstract] [Full Text] [PDF]

				V. Torrano, I. Chernukhin, F. Docquier, V. D'Arcy, J. Leon, E. Klenova, and M. D. Delgado CTCF Regulates Growth and Erythroid Differentiation of Human Myeloid Leukemia Cells J. Biol. Chem., July 29, 2005; 280(30): 28152 - 28161. [Abstract] [Full Text] [PDF]